Kazumasa Hirata
VICE PRESIDENT
CORPORATE DEVELOPMENT
Cutanea Life Sciences
United States of America
Biography
Kazumasa Hirata’s resume includes more than 15 years of pharmaceutical industry experience specializing in dermatological drug development. Dr. Hirata began his career as a pharmacokinetics researcher, responsible for conducting ADME [Absorption, Distribution, Metabolism and Excretion] studies for drug candidate applications to PMDA [Pharmaceuticals and Medical Devices Agency], the chief regulatory authority in Japan. He has served as Project Manager in the United Kingdom, overseeing and managing drug development projects in the therapeutic categories of pruritus associated with atopic dermatitis, psoriasis, genital herpes and herpes zoster. Dr. Hirata joined Cutanea Life Sciences in February, 2016, as Vice President of Corporate development. Dr. Hirata obtained his Ph.D. from The School of Pharmacy, University of London (presently UCL School of Pharmacy). The title of his thesis was “Topical Formulation Strategies for a Model Acidic and a Model Basic Drug.”
Research Interest
Dermatological Drug Development
